More Than $22 Million Headed to Indianapolis for Groundbreaking Medical Research
September 30, 2009
September 30, 2009
Washington, D.C. – Today, Congressman Carson announced that Indiana University-Purdue University Indianapolis (IUPUI) and Indiana Nanotech, LLC have been awarded several grants by the National Institutes of Health (NIH), totaling more than $22.3 million.
This landmark infusion is part of a $5 billion investment under the American Recovery and Reinvestment Act to support cutting-edge medical research across the country. Nationwide, the NIH grant program is expected to spur tens of thousands of new jobs within the health-care sector.
"As a hub for some of the most cutting-edge medical research in the nation, this huge investment only strengthens Indianapolis' reputation as a leader in the life sciences," said Congressman Carson. "Today's announcement is both a life-changer for our workforce, as well as a life-saver for families and individuals who will benefit from future innovation and research supported by these grants."
More on the NIH Grants
Today's grant announcement included 67 grants for IUPUI, totaling more than $2.3 million, with $100,000 in funding going to Indiana Nanotech. These awards will support the full spectrum of medical innovation—from basic research to clinical and translational studies. The Recovery Act-funded NIH grants focus on several areas, including heart disease, autism, HIV-AIDS, H1N1 Flu and cancer.
Much of this funding will also be dedicated to research applying the technology produced by the Human Genome Project between 1990 and 2003. This new funding will allow researchers to make quantum leaps forward in studying the genomic changes linked to cancer, heart, lung, and blood disease and autism– potentially leading to new treatments and cures.
###